Egalet (STU:EGP) ROCE %: -39.78% (As of Mar. 2020)


What is Egalet ROCE %?

Egalet STU:EGP ROCE % is -39.78% as of Mar. 2020. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Egalet's annualized ROCE % for the quarter that ended in Mar. 2020 was -39.78%.

Egalet  (STU:EGP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Egalet ROCE % Related Terms

Egalet ROCE % Historical Data

* Premium members only.

The historical data trend for Egalet's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet ROCE % Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
ROCE %
Get a 7-Day Free Trial Premium Member Only -53.26 -68.86 -57.14 -105.49 0.00

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -35.52 -15.87 0.00 -39.78

Egalet ROCE % Calculation

Egalet's annualized ROCE % for the fiscal year that ended in Dec. 2019 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=0/( ( (54.439 - 29.134) + (207.348 - 68.194) )/ 2 )
=0/( (25.305+139.154)/ 2 )
=0/82.2295
=0.00 %

Egalet's ROCE % of for the quarter that ended in Mar. 2020 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2020 )  (Q: Dec. 2019 )(Q: Mar. 2020 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2020 )  (Q: Dec. 2019 )(Q: Mar. 2020 )
=-52.24/( ( (207.348 - 68.194) + (207.678 - 84.202) )/ 2 )
=-52.24/( ( 139.154 + 123.476 )/ 2 )
=-52.24/131.315
=-39.78 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2020) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -39.78% mean?
Egalet (STU:EGP) has a ROCE % of -39.78% as of Mar. 2020.
Is Egalet's ROCE % too high?
Egalet's current ROCE % is -39.78%.
How does Egalet's ROCE % compare to CPHI and TLGT?
Egalet's ROCE % of -39.78% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Egalet's current ROCE % is -39.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current ROCE % of -39.78%. The current ROCE % is -39.78%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Egalet (STU:EGP), the current ROCE % is -39.78% as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.